Immuneering (IMRX) Receivables (2020 - 2023)

Immuneering's Receivables history runs 4 years deep, the most recent figure standing at $1046.0 for Q1 2023.

• In Q1 2023, Receivables fell 99.63% year-over-year to $1046.0; the TTM figure through Mar 2023 stood at $1046.0 (down 99.63% YoY), while the FY2022 annual figure was $12417.0, down 94.95% from the prior year.
• Receivables for Q1 2023 stood at $1046.0, down from $12417.0 in the prior quarter.
• The five-year high for Receivables was $500110.0 in Q4 2020, with the low at $1046.0 in Q1 2023.
• The 4-year median for Receivables is $246040.0 (2021), against an average of $250479.1.
• The sharpest annual moves came in 2021 and 2023: Receivables slumped 50.8% in 2021, then plunged 99.63% in 2023.
• Immuneering's Receivables stood at $500110.0 in 2020, then plunged by 50.8% to $246040.0 in 2021, then sank by 94.95% to $12417.0 in 2022, then slumped by 91.58% to $1046.0 in 2023.
• Business Quant data shows IMRX's Receivables at $1046.0 in Q1 2023, $12417.0 in Q4 2022, and $70180.0 in Q3 2022.